Cardiac cGMP Signaling in Health and Disease: Location, Location, Location
- 1 May 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 75 (5) , 399-409
Abstract
3′,5′-Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger, which critically regulates cardiac pump function and protects from the development of cardiac hypertrophy by acting in various subcellular microdomains. Although clinical studies testing the potential of cGMP elevating drugs in patients suffering from cardiac disease showed promising results, deeper insight into the local actions of these drugs at the subcellular level are indispensable to inspire novel therapeutic strategies. Detailed information on the spatio-temporal dynamics of cGMP production and degradation can be provided by the use of fluorescent biosensors that are capable of monitoring this second messenger at different locations inside the cell with high temporal and spatial resolution. In this review, we will summarize how these emerging new tools have improved our understanding of cardiac cGMP signaling in health and disease, and attempt to anticipate future challenges in the field.Keywords
This publication has 107 references indexed in Scilit:
- Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase IEuropean Heart Journal, 2011
- Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activationJournal of Molecular and Cellular Cardiology, 2010
- Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytesProceedings of the National Academy of Sciences, 2010
- PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylationBasic Research in Cardiology, 2010
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeuticsPharmacology & Therapeutics, 2009
- Probing the Interaction between the Coiled Coil Leucine Zipper of cGMP-dependent Protein Kinase Iα and the C Terminus of the Myosin Binding Subunit of the Myosin Light Chain PhosphataseJournal of Biological Chemistry, 2008
- High blood pressure arising from a defect in vascular functionProceedings of the National Academy of Sciences, 2008
- Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensorsProceedings of the National Academy of Sciences, 2008
- Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approachBiochemical Journal, 2007
- Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular CompartmentsJournal of General Physiology, 2006